Please login to the form below
deafness
This page shows the latest deafness news and features for those working in and with pharma, biotech and healthcare.
Pfizer spins out SpringWorks Therapeutics biotech
and a host of other complications including blindness, deafness, learning disabilities and pain.
Latest news
-
BioMarin's real world data sways NICE on orphan drug Vimizim
heart disease, dental and eye care, pain relief, and hearing aids and ventilating tubes to manage deafness and middle ear effusions. .
-
Hearing loss prevention drugs expected by 2020
Report by Action on Hearing Loss launched today
-
NICE backs Roche's MabThera in rare autoimmune disease
indication, with ANCA-associated vasculitis an umbrella term for several related conditions that usually affect the lungs, kidneys, ears, nose or sinuses, sometimes leading to organ damage, bleeding or deafness.
-
Novartis wins childhood arthritis indication for Ilaris in EU
The approval adds to Ilaris' existing approvals in the EU to treat the rare inflammatory disorder cryopyrin-associated periodic syndromes (CAPS), which can lead to deafness and loss of vision, and
-
Sanofi and Audion in hearing partnership
approach. The research will use technology developed at the Massachusetts Eye and Ear Infirmary in the Eaton-Peabody Laboratory, a basic research facility dedicated to the study of hearing and deafness,
More from news
Approximately 1 fully matching, plus 9 partially matching documents found.
Latest Intelligence
-
Significant figures
The liposome technology creates a shield that keeps most of the drug out of direct contact with a patient’s blood, successfully dodging Amikacin’s severe side effects, which include deafness,
-
The impending threat of antibiotic resistance
Pneumonia. 1 in 3 people died. Ear infection. Caused deafness. Surgery.
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Featured jobs
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
-
Associate Director
-
£75, 000-90, 000
- Global Business Development Director – Health Education
-
excellent commission
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
-
Account Director
-
Competitive Salary Offered
-
Business Director
-
Competitive Salary Offered
-
Medical Writer
-
Salary TBC
- Senior Account Director development role to Business Director, H...
-
Excellent package
-
Account Manager / Account Director
-
Competative
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Account Manager / Senior Account Manager
-
35, 000-40, 000
-
Senior Medical Writer
-
Salary TBC
-
Senior Account Manager
-
Competitive Salary Offered
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
-
Account Director, Medical Education
-
Salary TBC
Subscribe to our email news alerts
- Europe closer to biosimilar rule change, despite fierce resistance from pharma
- Novartis forges AI alliance with Oxford University
- FDA adcomm split on Sanofi’s type 1 diabetes drug
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Essential collaboration skills training for pharma and healthcare teams launched by Dovetail.
- Evenity back on track with FDA panel blessing in osteoporosis
PMHub
Pegasus
Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...
Latest intelligence
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Healthcare leaders in the European Union should begin preparing for a breakthrough now...
- The UK’s new five-year pricing agreement
- Pharma has agreed to capped growth again - in exchange for uptake promises...
- Digital applications are transforming the market access landscape
- Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Quick links
Infographics
